The E2F family of transcription factors provides temporal control of genes that are necessary for the G1/S-phase transition and are critical for controlling cell proliferation ([@bib8]; [@bib60]). In early G1 phase of the cell cycle, the RB family proteins bind to and inhibit E2F transcriptional activities. In late G1 to S phase, cyclin-dependent kinases (CDKs) phosphorylate the RB family proteins, which then dissociate, resulting in E2F liberation and activation of E2F-dependent transcription ([@bib8]; [@bib60]). E2F-regulated genes are required in dividing cells for proper DNA replication and subsequent mitosis ([@bib39]; [@bib44]). The basic unit of E2F is a heterodimer composed of an E2F and a DP subunit. Eight *E2F* genes have been characterized in mammals ([@bib53]; [@bib58]; [@bib60]): three activating E2Fs (E2F1∼3), two DP interacting repressive E2Fs (E2F4∼5), and three DP independent repressive E2Fs (E2F6∼8). The E2F family members display partial redundancy as well as antagonizing functions; thus, it is challenging to elucidate the functions of individual mammalian E2Fs. The RB-E2F pathway is streamlined in *Drosophila* because it contains only two E2Fs, the activator dE2F1 and the repressor dE2F2 ([@bib22]). Therefore, genetic and developmental analyses using *Drosophila* as a model organism may provide important insights into the mechanisms regulating the RB-E2F pathway during development.

We used a modifiable dE2F1 RNA interference system in *Drosophila* to identify novel regulators of E2F1 activity. By conducting a dominant modifier genetic screen, we have identified a set of genetic interactions between dE2F1 and members of the Polycomb group (PcG) genes. Several PcG complexes have been characterized, including polycomb repressive complex 1 (PRC1), PRC2, *Pho*-repressive complex (PhoRC), dRING-associated factors, and the Polycomb repressive deubiquitinase complex \[PR-DUB ([@bib31]; [@bib45]; [@bib46]; [@bib40]; [@bib34])\]. Of these complexes, the PRC2 contains the sole histone methyl-transferase, Enhancer of zeste (E(z)), specific for histone 3 lysine 27 (H3K27). Methylation of H3K27 by PRC2 is shown to facilitate the recruitment of the PRC1 complex through direct binding with the chromodomain of Polycomb (Pc) ([@bib11]; [@bib21]; [@bib36]; [@bib10]). However, *in vivo* regulations of these complexes in development are less well understood.

There are several reports linking PcG complexes to the RB-E2F pathway in vertebrates. First, the *INK4b-ARF-INK4a* tumor suppressor locus is regulated by the PcG complexes ([@bib23]). The *INK4b-ARF-INK4a* locus is vertebrate-specific and encodes the INK4 family of inhibitors that target CDK4/6-cyclin D (CycD), which phosphorylate and inactivate pRB family members in mammals ([@bib47]; [@bib23]). Second, RB was reported to regulate the G2/M-phase transition by forming an E2F-RB-CtBP-HPC2 complex, thus repressing the expression of cyclin A and Cdc2 in cultured human cells ([@bib15]). Third, E2F6, one of the repressive E2F family members in mammals, forms complexes with RYBP, Bmi1, EPC1, and other PcG subunits ([@bib59]; [@bib41]; [@bib1]) and regulates Hox gene expression and axial skeleton development in mouse ([@bib54]; [@bib14]). Finally, the RB-E2F pathway has been shown to regulate the expression of certain PcG subunits, such as EZH2 and EED ([@bib4]). Although it is not known whether these mechanisms are conserved in evolution, these studies suggest that the interactions between the RB-E2F pathway and PcG-mediated silencing can occur at multiple levels.

In *Drosophila*, PcG complexes have been reported to regulate the expression of several cell-cycle regulators. Polycomb responsive elements have been identified in the promoter and coding region of *dCycA* and *dE2f1* ([@bib35]). Similarly, the PhoRC subunit Pleiohomeotic (Pho) and the PRC1 component Ph are found at the promoters of *dCycB*, *dDp*, *dE2f1*, and *Rbf1* in *Drosophila* embryos ([@bib42]). These studies suggest a direct role for multiple PcG complexes in regulating key Rb-E2F pathway components and that PcG complexes may affect cell proliferation by controlling the expression of different cell-cycle regulators in development. The relationships between PcG complexes and cell proliferation in different developmental contexts are important and far from clear, thus further investigations using diverse model systems and approaches are necessary.

We have identified a set of genetic interactions between PcG genes and dE2F1. As summarized in this report, our results suggest that PcG complexes may directly repress the transcription of *dE2f1* and certain dE2F1 target genes. Together with the previous reports linking PcG complexes to cell-cycle regulators ([@bib35]; [@bib42]), our genetic analyses provide *in vivo* evidence that supports a role for different PcG complexes in coordinating cell proliferation and differentiation during *Drosophila* development by controlling the expression of several key cell-cycle regulators.

Materials and Methods {#s1}
=====================

Generation of *UAS-dE2f1-dsRNA* (tissue-specific *dE2f1*-RNAi) transgenic lines {#s2}
-------------------------------------------------------------------------------

A 650-bp fragment of DNA sequence was amplified by polymerase chain reaction (PCR) using *dE2f1* cDNA as the template, and the primer sequences were 5′-TTATTTCAAACGCCCTACCG-3′ and 5′-GAATTGCATCTGCAGTGAGC-3′. This fragment was previously used as the target sequence to generate double-strand RNA (dsRNA) in our microarray analyses for dE2F1 target genes ([@bib16]). The PCR product was gel purified and subsequently subcloned into the pWIZ vector in an inverted configuration \[for the detailed procedure, see ([@bib29])\] and verified by sequencing. The final *pWIZ-dE2f1-dsRNA* vector, as referred to as "*UAS-dE2f1-dsRNA*" in the text, was injected into early *Drosophila* embryos (*[w^1118^](http://flybase.org/reports/FBal0018186.html)*) to generate transgenic flies. Approximately 30 different transgenic lines carrying one or multiple transgenes, as indicated by their eye color because pWIZ carries mini-*[white](http://flybase.org/reports/FBgn0003996.html)* as a selection marker, were balanced, crossed, and recombined with different Gal4 lines using standard genetic crosses. Because the *dE2f1dsRNA* phenotypes in both the eye (*[w^1118^](http://flybase.org/reports/FBal0018186.html)*; *GMR-Gal4*, *UAS-dE2f1RNAi \#10* or *\#8/+*; *+/+* at 25°) and the wing (*[w^1118^](http://flybase.org/reports/FBal0018186.html)*; *ptc-Gal4*, *UASdE2f1dsRNA\#3/+*; *+/+* at 22∼23°) are modifiable by known RB-E2F pathway factors in expected manners and the phenotypes are fully penetrate, these two recombined stocks were used for genetic analyses in this work.

Genetic screen using the Exelixis deficiency (*Df*) lines {#s3}
---------------------------------------------------------

Flies were maintained on standard cornmeal-yeast agar medium. Exelixis *Df* lines and most of the mutant alleles used in this work were obtained from the Bloomington *Drosophila* Stock Center. The null allele of *[Polycomb](http://flybase.org/reports/FBgn0003042.html)* (*[Pc^3^](http://flybase.org/reports/FBal0013553.html)*) allele was obtained from Dr. Antonio Garcia-Bellido ([@bib12]). For genetic screen using the Exelixis *Df* lines: approximately 5∼10 female virgins from either *[w^1118^](http://flybase.org/reports/FBal0018186.html)*; *GMR-Gal4*, *UAS-dE2f1RNAi \#10* (or *\#8*)/*CyO*; *+/+*, or *[w^1118^](http://flybase.org/reports/FBal0018186.html)*; *ptc-Gal4*, *UASdE2f1dsRNA\#3/CyO*; *+/+* lines were crossed with 5∼10 males from each *Df* line on second or third chromosomes, and the crosses were maintained at either 25° (for the eye phenotype) or 22∼23° (for the wing phenotype). As an example for the eye phenotype, the female F1 with the following genotypes were scored for potential modifications: *[w^1118^](http://flybase.org/reports/FBal0018186.html)*; *GMR-Gal4*, *UAS-dE2f1RNAi \#10/Df(2R/2L)Exel\#*; *+*, or *[w^1118^](http://flybase.org/reports/FBal0018186.html)*; *GMR-Gal4*, *UAS-dE2f1RNAi \#10/+*; *Df(3R/3L)Exel\#/+*. The reverse crosses were performed for *Df* lines on the X chromosome and F1 female flies with the following genotype were scored: *Df(1)Exel\#/w^1118^*; *GMR-Gal4*, *UAS-dE2f1RNAi \#10/+*; *+/+*.

Scanning electron microscopy and measurement of the L3-L4 intervein region {#s4}
--------------------------------------------------------------------------

The F1 female flies were stepwise dehydrated using ethanol, and scanning electron micrographs were taken following standard procedures at the Northeastern University. To measure L3-L4 intervein region, wings are removed, briefly treated with isopropanol and then mounted in Canada Balsam (Sigma-Aldrich, St. Louis, MO). The width of L3-L4 was measured under a Nikon i90 microscope using the Nikon NIS Elements software.

*Drosophila* RNAi in SL2 cells and the MTT assay {#s5}
------------------------------------------------

The dsRNAs used in this work were synthesized using the RiboMax Large Scale RNA Production Systems (Promega, Madison, WI) following the manufacturer's instructions. The following primer sets were used to generate dsRNAs to *dE2f1* (F: 5′-CGAGTAAGAAGCAGCAGCAC; R: 5′-CTGCCGGTTCTATCGTGATT), *[Su(z)2](http://flybase.org/reports/FBgn0008654.html)* (F: 5′-TCTGCTACCGGATTCTGCTTTACG; R: 5′-AACTCCCTTTCGATTCGCTGTCTT), *[Psc](http://flybase.org/reports/FBgn0005624.html)* (F: 5′-CAACGCCAAGCCGAACATCAAATC; R: 5′-AGCGGCTGGGGCGACTCATAAAC), *[Pc](http://flybase.org/reports/FBgn0003042.html)* (F: 5′-TGCCAATGCAATAGATTGTAAA; R: 5′-CGCTTTGAATTGCTGTTTTG), *[E(Pc)](http://flybase.org/reports/FBgn0000581.html)* (F: 5′-TCAGCCCTTCTACGATGCCTACTA; R: 5′-CTCGCGTCGCCTCACCATCTCCAG), and *[white](http://flybase.org/reports/FBgn0003996.html)* with T7 sequence (F: 5′-CTAATACGACTCACTATAGGGAGGGAAGATGGCTCCG; R: 5′-CTAATACGACTCACTATAGGGAGTTTCGCTCAGCAAATG). Treatment of the *Drosophila* SL2 cells with 50 μg of dsRNA was performed as described previously ([@bib16]). The *[white](http://flybase.org/reports/FBgn0003996.html)*-dsRNA was used as a control, and it is also used to normalize the total amount of dsRNA in codepletion experiments. The MTT assay was performed as described ([@bib26]) in 96-well format, and the O.D. at 570nm was measured using a standard plate-reader.

RNA preparation and quantitative reverse-transcription (qRT)-PCR analysis {#s6}
-------------------------------------------------------------------------

The total RNA isolation, quantification, reverse transcription, and the subsequent qRT-PCR analyses were performed as described previously ([@bib63]). The following primers were used for qRT-PCR for data presented in [Figure 4](#fig4){ref-type="fig"}: *[stg](http://flybase.org/reports/FBgn0003525.html)* (F: 5′-AAACCAGCTGCTCGGCATATT; R: 5′-ATCTCAATTCACCGAACGAGGA), *rnrL* (F-5′-CGGTTAAGGCTCAATCCCTGT; R: 5′-TGGTTGCTCTTCCTGTTGCA), *his2AvD* (F: 5′-TCACTCCTCGCCACTTACAGCT; R: 5′-CGACTTGTGTATGTGCGGAATG), *Mars* (F: 5′-ATCTTGGATCCTCAGCAGACGA; R: 5′-GGCATTCCATTGGATTCGC), *Mcm 5* (F: 5′-GAAGCTAAAGAGCCGCTACGTG; R: 5′-TCCAACTGACGCACAGTGATG), *PCNA* (F: 5′-GAATCGGCTAACCAGGAGAAGG; R: 5′-ACCACGCACGAGAAGTCTGTCT), *Nebbish* (F: 5′-AGTCGCATTGCCCTTAATCTGA; R: 5′-ATGTCTGTCGCGGTGTATTGC), *dE2f1* (F: 5′-CTCTTTCTCCGCGTGTGGATT; R: 5′-GCGACGAAAAGCGAACTGAA), *dCycA* (F: 5′-AACCACGAACCGCTGAACAA; R: 5′-GGCAGCGTTGGAATTAGTTT), *dCycE* (F: 5′-ATGTGGCGCATAAGGTGCA; R: 5′-CCCGATCTTTGGCGGATAA), and *rp49* gene (F: 5′-ACAGGCCCAAGATCGTGAAGA; R: 5′-CGCACTCTGTTGTCGATACCCT) was used as the internal loading control.

Results {#s7}
=======

Tissue-specific knockdown of dE2F1 activity produces modifiable phenotypes {#s8}
--------------------------------------------------------------------------

Homozygous *dE2f1* mutant animals die during larval development ([@bib17]); thus, we used a *dE2f1-dsRNA* expression system based on the pWIZ vector ([@bib29]). This system allows the tissue-specific expression of the target dsRNA ([@bib25]) using the Gal4-UAS system ([@bib5]; [@bib29]). We generated multiple transgenic lines that produce a 650-bp dsRNA from the *dE2f1* gene under control of the UAS, designated as "*UAS-dE2f1-dsRNA*" (see *Materials and Methods* for details). The *UAS-dE2f1-dsRNA* transgenes were then crossed to multiple tissue-specific Gal4 drivers and the resulting phenotypes were characterized. By driving the expression of *UAS-dE2f1-dsRNA* using the eye-specific *GMR-Gal4* and the wing-specific *patched-Gal4* (*ptc-Gal4*), we observed phenotypes with 100% penetrance and limited variation. Expression of *dE2f1-dsRNA* under the control of GMR-Gal4 caused a rough eye phenotype characterized by fused ommatidia ([Figure 1B](#fig1){ref-type="fig"}, compared with the control in [Figure 1A](#fig1){ref-type="fig"}), which we refer to as the "*dE2f1-dsRNA* eye phenotype" hereafter. Expression of *dE2f1-dsRNA* under the control of *ptc-Gal4* reduces the L3-L4 intervein region in the adult wing ([Figure 3B](#fig3){ref-type="fig"}, compared with the control in [Figure 3A](#fig3){ref-type="fig"}), which is referred as the "*dE2f1-dsRNA* wing phenotype."

![Tissue-specific expression of dE2f1-dsRNA generates phenotypes that can be modified by known factors of the dE2F1 pathway. (A) A normal *Drosophila* eye (*w^1118^*; *GMR-Gal4/*+; +/+). (B) Expressing one copy of the *UAS-dE2f1-dsRNA* (Line \#10) generates a slight rough eye phenotype (*w^1118^*; *GMR-Gal4*, *UAS-dE2f1dsRNA\#10/*+; +/+), which can be enhanced by reducing the endogenous *dE2f1* levels, as shown in (C) (*w^1118^*; *GMR-Gal4*, *UAS-dE2f1dsRNA\#10/*+; *dE2f1^i2^/*+), and completely rescued by overexpressing wild-type *dE2f1*, as shown in (D) (*w^1118^*; *GMR-Gal4*, *UAS-dE2f1dsRNA\#10/*+; *UAS-dE2f1*^+^/+). A stronger rough eye phenotype is generate when multiple copies of *UAS-dE2f1dsRNA* (line \#8) is expressed, as shown in (E) (*w^1118^*; *GMR-Gal4*, *UAS-dE2f1dsRNA\#8/*+; +/+). This stronger phenotype can be suppressed by overexpressing wild-type *dCycA* (F: *w^1118^*; *GMR-Gal4*, *UAS-dE2f1dsRNA\#8/*+; *UAS-dCycA*^+^/+), wild-type dCycE (G: *w^1118^*; *GMR-Gal4*, *UAS-dE2f1dsRNA\#8/UAS-dCycE*^+^; +/+), or *dCdk4* and *dCycD* (H: *w^1118^*; *GMR-Gal4*, *UAS-dE2f1dsRNA\#8/*+; *UAS-dCdk4*^+^, *UAS-dCycD*^+^/+). The scale bar (in H) is 200µm.](1651f1){#fig1}

To verify the specificity of the *dE2f1-dsRNA*−induced phenotypes, we recombined different *UAS-dE2f1-dsRNA* lines to the *GMR-Gal4* or *ptc-Gal4* drivers on the second chromosome (see *Materials and Methods*). Using these stocks, we then tested the capacity of components of the Rb-E2F pathway to modifying the phenotypes. We observed that the *[GMR](http://flybase.org/reports/FBgn0020433.html)*-driven rough eye phenotypes generated by a weak allele of *dE2f1-dsRNA* (line \#10; [Figure 1B](#fig1){ref-type="fig"}) were enhanced by mutant alleles of *dE2f1* ([Figure 1C](#fig1){ref-type="fig"}). In contrast, the rough-eye phenotypes can be suppressed by introducing a single copy of a *UAS-dE2f1^+^* transgene ([Figure 1D](#fig1){ref-type="fig"}). We observed that even the strong effects of *dE2f1-dsRNA* (line \#8; [Figure 1E](#fig1){ref-type="fig"}) were suppressed by the overexpression of wild-type dCycA ([Figure 1F](#fig1){ref-type="fig"}), dCycE ([Figure 1G](#fig1){ref-type="fig"}), or dCdk4-dCycD ([Figure 1H](#fig1){ref-type="fig"}). Conversely, mutant alleles of *dCdk4*, *dCycA*, or *dCycE* enhanced the *dE2f1-dsRNA* phenotypes (data not shown). These genetic analyses show that the *dE2f1-dsRNA* phenotypes are modified by components of the Rb-E2F pathway in a predictable manner, suggesting that the phenotypes are caused by specific reduction of dE2F1 activity. In support of this, we observed reduced dE2F1 protein levels in both immunostaining and Western blotting experiments when using tissue-specific expression of *dE2f1*-dsRNA ([@bib38]). We also find that knockdown of dE2F1 in the wing imaginal discs results in reduced expression of a PCNA-GFP reporter, which directly reflects endogenous dE2F1 activity ([@bib56]; [@bib38]). Taken together, these molecular and genetic analyses suggest that the *dE2f1-dsRNA* phenotypes result from the specific reduction of dE2F1 activity.

A dominant modifier genetic screen to identify novel regulators of dE2F1 activity {#s9}
---------------------------------------------------------------------------------

To identify novel regulators of dE2F1 *in vivo*, we performed a dominant modifier genetic screen based on the *dE2f1-dsRNA* phenotypes described previously. The initial screen used the Exelixis *Df* collection (459 lines), which was generated in an isogenic background and all of the breakpoints are molecularly defined ([@bib43]). We conducted a primary screen using the *dE2f1-dsRNA* eye phenotype because of ease of screening, and only *Df* lines that were able to modify this eye phenotype were subsequently retested using the *dE2f1-dsRNA* wing phenotype ([Figure 2A](#fig2){ref-type="fig"}). Thus, the *Df* lines that did not modify the *dE2f1-dsRNA* eye phenotype (referred to as "no effect" or "NE" in the tables) are excluded from further analysis (referred to as "not determined" or "ND" in the tables). Although this screen strategy may miss the modifiers that only affect the *dE2f1-dsRNA* wing phenotype, it enabled the identification of general regulators of E2F1 activity rather than tissue-specific modifiers.

![*Su(z)2* is a strong suppressor of the *dE2f1-dsRNA* phenotypes in the eye. (A) The design of the dominant modifier genetic screen using deficiency lines. (B-D) shows the modification of the *dE2f1-dsRNA* eye phenotype by *Su(z)2* alleles. The eye phenotype of *GMR-Gal4*, *UAS-dE2f1dsRNA\#8/*+ (B) flies can be strongly suppressed by the *Df(2R)Exel6062* line (C, the genotype is *w^1118^*; *GMR-Gal4*, *UAS-dE2f1dsRNA\#8/Df(2R)Exel6062*; +/+) and a null allele of *Su(z)2* (D, the genotype is *w^1118^*; *GMR-Gal4*, *UAS-dE2f1dsRNA\#8/Su(z)2^1.b7^*; +/+). (E) Summary of the genetic interactions between *Su(z)2* alleles and *dE2f1-dsRNA* phenotypes in the eye and wing. The suppressive effect was ranked with scores from 1 to 5, with "1" being the weakest and "5" the strongest. "0" means no genetic interaction. The scale bar in (D) is 200µm.](1651f2){#fig2}

From these screens, we identified 18 suppressor *Df* lines ([Table 1](#t1){ref-type="table"}) and 23 enhancer *Df* lines ([Table 2](#t2){ref-type="table"}) that modified both *dE2f1-dsRNA* phenotypes in the same fashion. The results of all Exelixis *Df* lines are summarized in [Supporting Information](http://www.g3journal.org/lookup/suppl/doi:10.1534/g3.112.004333/-/DC1/004333SI.pdf), [Table S1](http://www.g3journal.org/lookup/suppl/doi:10.1534/g3.112.004333/-/DC1/TableS1.xls). Because the *dE2f1-dsRNA* phenotypes are based on RNAi, we tested the modifier *Df* lines on the *GMR \> white-Inverted Repeat* (*GMR-w^IR^*) line, to identify gene products that change RNAi efficiency rather than the E2F1 directly ([@bib30]). None of the enhancers and suppressors of the *dE2f1-dsRNA* phenotypes affected the *GMR-w^IR^* eye color ([Table 1](#t1){ref-type="table"} and [Table 2](#t2){ref-type="table"}), suggesting that the modifiers identified in our screen are *bona fide* regulators of dE2F1.

###### Exelixis *Df* lines that dominantly suppress the *dE2f1-dsRNA* phenotypes

  Bloomington Stock No.   Symbol           Breakpoints   *GMR-Gal4,UAS-dE2f1-dsRNA\#10*[*^a^*](#t1n1){ref-type="table-fn"}^,^[*^b^*](#t1n2){ref-type="table-fn"}   *ptc-Gal4,UAS-dE2f1-dsRNA\#3*[*^a^*](#t1n1){ref-type="table-fn"}^,^[*^c^*](#t1n3){ref-type="table-fn"}   *GMR-w^IR^* [*^a^*](#t1n1){ref-type="table-fn"}
  ----------------------- ---------------- ------------- --------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------- -------------------------------------------------
  7699                    Df(1)Exel6221    1B4;1B8       5                                                                                                         2                                                                                                        NE
  7700                    Df(1)Exel6223    1C4;1D2       5                                                                                                         4                                                                                                        NE
  7723                    Df(1)Exel6255    20A1;20B1     5                                                                                                         3                                                                                                        NE
  7772                    Df(2L)Exel7002   21B4;21B7     5                                                                                                         2                                                                                                        NE
  7774                    Df(2L)Exel8003   21D1;21D2     5                                                                                                         2                                                                                                        NE
  7489                    Df(2L)Exel6002   21D2;21D3     5                                                                                                         5                                                                                                        NE
  8000                    Df(2L)Exel6006   22B5;22D1     5                                                                                                         2                                                                                                        NE
  7817                    Df(2L)Exel8024   31A2;31B1     5                                                                                                         2                                                                                                        ND
  7531                    Df(2L)Exel6049   40A5;40D3     5                                                                                                         1                                                                                                        NE
  7540                    Df(2R)Exel6058   44C4;44D1     5                                                                                                         2                                                                                                        NE
  7544                    Df(2R)Exel6062   49E6;49F1     5                                                                                                         4                                                                                                        NE
  7880                    Df(2R)Exel9015   51F11;51F12   5                                                                                                         1                                                                                                        NE
  7883                    Df(2R)Exel7138   52D1;52D12    5                                                                                                         1                                                                                                        NE
  7557                    Df(2R)Exel6077   57F10;58A3    5                                                                                                         4                                                                                                        NE
  7903                    Df(2R)Exel7173   58D4;58E5     5                                                                                                         2                                                                                                        NE
  7921                    Df(3L)Exel9000   64A10;64B1    5                                                                                                         2                                                                                                        NE
  7927                    Df(3L)Exel7210   65A1;65A5     5                                                                                                         2                                                                                                        NE
  7992                    Df(3R)Exel9014   95B1;95D1     5                                                                                                         1                                                                                                        NE

The suppressive effect was ranked with scores from 1 to 5, with "1" the weakest and "5" the strongest. ND, not determined (this line is no longer available from the Bloomington stock center); NE, no effect.

These crosses were maintained at 25°.

These crosses were maintained at 22-23°; see *Materials and Methods* for the detailed genotypes analyzed.

###### Twenty-three enhancers from the Exelixis Df lines

  Bloomington Stock No.   Symbol           Breakpoints   *GMR-Gal4,UAS-dE2f1- dsRNA\#10*[*^a^*](#t2n1){ref-type="table-fn"}^,^[*^b^*](#t2n2){ref-type="table-fn"}   *ptc-Gal4,UAS-dE2f1- dsRNA\#3*[*^a^*](#t2n1){ref-type="table-fn"}^,^[*^c^*](#t2n3){ref-type="table-fn"}   *GMR-w^IR^* [*^a^*](#t2n1){ref-type="table-fn"}
  ----------------------- ---------------- ------------- ---------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------- -------------------------------------------------
  7510                    Df(2L)Exel6027   32D2;32D5     5                                                                                                          Lethal                                                                                                    NE
  7519                    Df(2L)Exel6036   35B1;35B2     3                                                                                                          5                                                                                                         NE
  7859                    Df(2R)Exel7094   44A4;44B4     3                                                                                                          4                                                                                                         NE
  7538                    Df(2R)Exel6056   44A4;44C2     4                                                                                                          5                                                                                                         NE
  7896                    Df(2R)Exel7162   56F11;56F16   2                                                                                                          3                                                                                                         NE
  7554                    Df(2R)Exel6072   57B16;57D4    2                                                                                                          Lethal                                                                                                    NE
  7902                    Df(2R)Exel7171   58C1;58D2     5                                                                                                          Lethal                                                                                                    NE
  7745                    Df(3L)Exel6279   66A17;66B5    4                                                                                                          2                                                                                                         NE
  7602                    Df(3L)Exel6123   70D7;70E4     Pupal lethal                                                                                               Lethal                                                                                                    NE
  7611                    Df(3L)Exel6132   74B2;74D2     3                                                                                                          1                                                                                                         NE
  7614                    Df(3L)Exel6135   76B11;76C4    5                                                                                                          Lethal                                                                                                    NE
  7624                    Df(3R)Exel6145   83C1;83C4     5                                                                                                          Lethal                                                                                                    NE
  7627                    Df(3R)Exel6148   84F12;85A2    Pupal lethal                                                                                               Lethal                                                                                                    NE
  7632                    Df(3R)Exel6153   85D21;85E1    3                                                                                                          3                                                                                                         NE
  7633                    Df(3R)Exel6154   85E9;85F1     4                                                                                                          2                                                                                                         NE
  7732                    Df(3R)Exel6265   85F10;85F16   4                                                                                                          2                                                                                                         NE
  7636                    Df(3R)Exel6157   86B1;86B3     5                                                                                                          2                                                                                                         NE
  7641                    Df(3R)Exel6162   87A1;87B5     Pupal lethal                                                                                               Lethal                                                                                                    NE
  7649                    Df(3R)Exel6170   87F10;87F14   1                                                                                                          5                                                                                                         NE
  7742                    Df(3R)Exel6275   88D1;88D7     5                                                                                                          Pupal lethal                                                                                              NE
  7659                    Df(3R)Exel6180   91B5;91C5     3                                                                                                          3                                                                                                         NE
  7678                    Df(3R)Exel6199   95F8;96A2     3                                                                                                          5                                                                                                         NE
  7993                    Df(3R)Exel8178   95F8;96A6     3                                                                                                          4                                                                                                         NE

The effect of enhancement was ranked with scores from 1 to 5, with "1" the weakest and "5" the strongest. NE, no effect.

These crosses were maintained at 25°.

These crosses were maintained at 22-23°; See *Materials and Methods* for the detailed genotypes analyzed.

*Su(z)2* is a strong suppressor of the *dE2f1-dsRNA* phenotypes {#s10}
---------------------------------------------------------------

One of the strongest suppressors (*[Df(2R)Exel6062](http://flybase.org/reports/FBab0038000.html)*) of the *dE2f1-dsRNA* phenotypes was reported to delete only one characterized gene, *[Su(z)2](http://flybase.org/reports/FBgn0008654.html)* ([@bib43]). *[Df(2R)Exel6062](http://flybase.org/reports/FBab0038000.html)* suppressed both the eye phenotype ([Figure 2C](#fig2){ref-type="fig"} compared to the control [Figure 2B](#fig2){ref-type="fig"}) and the wing phenotype ([Figure 3C](#fig3){ref-type="fig"} compared to the control [Figure 3B](#fig3){ref-type="fig"}). The *[Df(2R)Exel6062](http://flybase.org/reports/FBab0038000.html)* line deletes a region of ∼54kb between two *P*-element (XP vector) insertion lines *d09185* and *d02103* ([@bib43]; [@bib57]). This deletion starts at 190bp region upstream of the neighboring gene *Posterior sex comb* (*[Psc](http://flybase.org/reports/FBgn0005624.html)*), and includes *[CG33798](http://flybase.org/reports/FBgn0053798.html)* (an uncharacterized gene with unknown function) and the *[Su(z)2](http://flybase.org/reports/FBgn0008654.html)* gene ([@bib43]).

![*Su(z)2* and additional PcG genes are strong suppressors of the *dE2f1-dsRNA* phenotypes in the wing. (A) Part of L3-L4 intervein region of a control *Drosophila* wing (*ptc-Gal4/*+). Ptc-Gal4 is expressed in the L3-L4 intervein region. At 22∼23°, when *dE2f1-dsRNA* (line \#3) is expressed under control of *ptc-Gal4*, the L3-L4 intervein region is reduced by ∼50%, as shown in (B) (*w^1118^*; *ptc-Gal4*, *UAS-dE2f1dsRNA\#3/*+; +/+). This wing phenotype can be strongly suppressed by *Df(2R)Exel6062* (C: *w^1118^*; *ptc-Gal4*, *UAS-dE2f1dsRNA\#3/Df(2R)Exel6062*; +/+), or the *Su(z)2^1.a1^* allele (D: *w^1118^*; *ptc-Gal4*, *UAS-dE2f1dsRNA\#3/Su(z)2^1.a1^*; +/+). The modification of the wing phenotype can be quantified by measuring the width of L3-L4 intervein region (E), and the genotypes of data presented in (E) are as follows: (*a*) *w^1118^*; *ptc-Gal4/*+; +; (*b*) *w^1118^*; *ptc-Gal4*, *UAS-dE2f1dsRNA\#3/*+; +; (*c*) *w^1118^*; *ptc-Gal4*, *UAS-dE2f1dsRNA\#3/Df(2R)Exel6062*; +/+; (*d*) *w^1118^*; *ptc-Gal4*, *UAS-dE2f1dsRNA\#3/Su(z)2^1^*; +/+; (*e*) *w^1118^*; *ptc-Gal4*, *UAS-dE2f1dsRNA\#3/Su(z)2^1.b7^*; +/+; (*f*) *w^1118^*; *ptc-Gal4*, *UAS-dE2f1dsRNA\#3/Su(z)2^1.a1^*; +/+; and (*g*) *w^1118^*; *ptc-Gal4*, *UAS-dE2f1dsRNA\#3/Su(z)2^k06344^*; +/+; (*h*) *w^1118^*; *ptc-Gal4*, *UAS-dE2f1dsRNA\#3/*+; *Pc^f01890^/*+; (*i*) *w^1118^*; *ptc-Gal4*, *UAS-dE2f1dsRNA\#3/*+; *Pc^3^/*+; (*j*) *w^1118^*; *ptc-Gal4*, *UAS-dE2f1dsRNA\#3/*+; *His2AvD^810^/*+; and (*k*) *w^1118^*; *ptc-Gal4*, *UAS-dE2f1dsRNA\#3/*+; *His2AvD^05146^/*+. At least 15 to 25 wings of each genotype (*a∼k*) were measured. Each genotype (*c∼k*) was compared with the control (*b*: *w^1118^*; *ptc-Gal4*, *UAS-dE2f1dsRNA\#3/*+; +) and each comparison is highly significant (*P* \< 4.9E-06 based on one-tailed *t*-test). For simplicity, "*ptc-Gal4*, *UAS-dE2f1dsRNA\#3*" is referred as "PE3" in (E). The scale bar in (D) is 100µm.](1651f3){#fig3}

To validate the suppressor gene of the *dE2f1-dsRNA* phenotypes, we tested the capacity of additional alleles of *[Su(z)2](http://flybase.org/reports/FBgn0008654.html)* from the Bloomington stock center (Su*(z)2^1^*, *[Su(z)2^1.a1^](http://flybase.org/reports/FBal0045153.html)*, *[Su(z)2^1.b7^](http://flybase.org/reports/FBal0028570.html)*, *Su(z)2^1.b8^*, *Su(z)2^4d1^*, Su*(z)2^k06344^*) to modify the *dE2F1-RNAi* phenotypes (mutant alleles of *[CG33798](http://flybase.org/reports/FBgn0053798.html)* are unavailable). These *[Su(z)2](http://flybase.org/reports/FBgn0008654.html)* mutant alleles strongly suppressed the *dE2f1-dsRNA* (line \#10) eye phenotype, and to a less extent with the strong eye phenotype generated by *dE2f1-dsRNA* (line \#8; [Figure 2E](#fig2){ref-type="fig"}). Next, we validated these genetic interactions identified in the eye by testing the effect of *[Su(z)2](http://flybase.org/reports/FBgn0008654.html)* mutants on the *dE2f1-dsRNA* wing phenotype. Reducing *[Su(z)2](http://flybase.org/reports/FBgn0008654.html)* by either *[Df(2R)Exel6062](http://flybase.org/reports/FBab0038000.html)* ([Figure 3C](#fig3){ref-type="fig"}) or *[Su(z)2^1.a1^](http://flybase.org/reports/FBal0045153.html)* ([Figure 3D](#fig3){ref-type="fig"}) increased the L3-L4 intervein region of *ptc-Gal4 UAS-dE2f1-dsRNA* flies compared with controls (*ptc-Gal4 UAS-dE2f1-dsRNA/+*, [Figure 3B](#fig3){ref-type="fig"}). Measurement of L3-L4 distance demonstrated significant rescue of the intervein distance by these *[Su(z)2](http://flybase.org/reports/FBgn0008654.html)* alleles compared to the control ([Figure 3E](#fig3){ref-type="fig"}). Together, these genetic analyses suggest that *[Su(z)2](http://flybase.org/reports/FBgn0008654.html)* is a strong suppressor of *dE2f1-dsRNA* phenotypes.

We then sought to extend this observation by examining additional *[Su(z)2](http://flybase.org/reports/FBgn0008654.html)* alleles described recently ([@bib20]). We examined the capacity of *[Su(z)2](http://flybase.org/reports/FBgn0008654.html)* point mutant alleles (*Su(z)2^s15^*, *Su(z)2^s20^*, *Su(z)2^s21^*, *Su(z)2^s36^*, *Su(z)2^s84^*, *Su(z)2^s95^*, and *Su(z)2^sM^*) to suppress the *dE2f1-dsRNA* phenotypes. However, we did not observe any obvious modification of the *E2F1-dsRNA* phenotypes (data not shown), indicating that these particular *[Su(z)2](http://flybase.org/reports/FBgn0008654.html)* point mutations are insufficient to modify these phenotypes. Similarly, we did not observe any genetic interactions between *dE2f1* and multiple alleles of the *[Su(z)2](http://flybase.org/reports/FBgn0008654.html)* paralog, *[Psc](http://flybase.org/reports/FBgn0005624.html)* (*Psc^s14^*, *[Psc^e22^](http://flybase.org/reports/FBal0038968.html)*, *[Psc^h27^](http://flybase.org/reports/FBal0045018.html)*, *[Psc^EY06547^](http://flybase.org/reports/FBal0159975.html)*, and *[Psc^k07804^](http://flybase.org/reports/FBal0065014.html)*; data not shown), suggesting that *[Su(z)2](http://flybase.org/reports/FBgn0008654.html)* and *[Psc](http://flybase.org/reports/FBgn0005624.html)* are not functionally redundant in these genetic analyses.

Multiple PcG and PcG-related genes suppress the *dE2f1-dsRNA* phenotypes {#s11}
------------------------------------------------------------------------

Having identified *[Su(z)2](http://flybase.org/reports/FBgn0008654.html)* as a suppressor of the *dE2f1-dsRNA* phenotypes, we tested whether mutants other than Polycomb family members, as well as genes that genetically interact with PcG, such as E(Pc) ([@bib27]; [@bib9]), Mi-2 ([@bib28]), and His2AvD ([@bib55]), could modify the *dE2f1-dsRNA* phenotypes. We observed that mutations of *[Pc](http://flybase.org/reports/FBgn0003042.html)*, *[pho](http://flybase.org/reports/FBgn0002521.html)*, *[Su(z)12](http://flybase.org/reports/FBgn0020887.html)*, *[Scm](http://flybase.org/reports/FBgn0003334.html)*, and *His2AvD* suppressed the *dE2f1-dsRNA* phenotypes, whereas *[E(Pc)](http://flybase.org/reports/FBgn0000581.html)* and *[Mi-2](http://flybase.org/reports/FBgn0262519.html)* behaved as enhancers ([Table 3](#t3){ref-type="table"}, [Figure 3E](#fig3){ref-type="fig"}). Importantly, components of three PcG complexes, including PRC 1 complex (*[Pc](http://flybase.org/reports/FBgn0003042.html)*, *[Scm](http://flybase.org/reports/FBgn0003334.html)*), PRC2 (*Esc*, *[Su(z)12](http://flybase.org/reports/FBgn0020887.html)*), and PhoRC (*Pho*), were able to suppress the *dE2f1-dsRNA* phenotypes ([Table 3](#t3){ref-type="table"}), suggesting that PcG may repress dE2F1 activities. In addition, we observed that mutant alleles of several PcG/TrxG genes, such as *[ash2^1^](http://flybase.org/reports/FBal0000757.html)*, *[crm^7^](http://flybase.org/reports/FBal0001834.html)*, Dsp1^EP355^, *[eff^8^](http://flybase.org/reports/FBal0028176.html)*, *[lid^10424^](http://flybase.org/reports/FBal0008148.html)*, *[lid^k06801^](http://flybase.org/reports/FBal0064675.html)*, *[Pcl^EY08457^](http://flybase.org/reports/FBal0160041.html)*, *[Sce^1^](http://flybase.org/reports/FBal0015263.html)*, *[trx^1^](http://flybase.org/reports/FBal0017165.html)*, *[trx^EY13717^](http://flybase.org/reports/FBal0158545.html)*, showed variable genetic interactions ranging from suppression to no effect and enhancement of varied degrees (data not shown). These variable interactions might reflect the dynamic and complex interactions *in vivo*.

###### Some of the PcG and TrxG genes dominantly modify the phenotypes caused by varied dE2F1 and RBF1 in the *Drosophila* eye and wing

  Mutant Alleles        *GMR-Gal4,UAS-dE2f1-dsRNA\#10*[*^a^*](#t3n1){ref-type="table-fn"}^,^[*^b^*](#t3n2){ref-type="table-fn"}   *ptc-Gal4,UAS-dE2f1-dsRNA\#3*[*^a^*](#t3n1){ref-type="table-fn"}^,^[*^b^*](#t3n2){ref-type="table-fn"}   *Act88F-Gal4,UASdE2f*[*^a^*](#t3n1){ref-type="table-fn"}^,^[*^b^*](#t3n2){ref-type="table-fn"}   *GMR-Gal4,UASdE2f1*, *UAS-dDp*[*^a^*](#t3n1){ref-type="table-fn"}^,^[*^b^*](#t3n2){ref-type="table-fn"}
  --------------------- --------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------ ---------------------------------------------------------------------------------------------------------
  Suppressors                                                                                                                                                                                                                                                                                                                               
  * Asx^1^*             Suppression (5)                                                                                           Suppression (1)                                                                                          Enhancement (1)                                                                                  NE
  * eff^mer4^*          Suppression (5)                                                                                           Suppression (2)                                                                                          NE                                                                                               NE
  * E(Pc)84DE^T66.1^*   Suppression (5)                                                                                           Suppression (1)                                                                                          NE                                                                                               NE
  * esc^1^*             Suppression (4)                                                                                           NE                                                                                                       ND                                                                                               ND
  * esc^21^*            Suppression (5)                                                                                           Suppression (4)                                                                                          ND                                                                                               ND
  * His2AvD^810^*       Suppression (5)                                                                                           Suppression (2)                                                                                          ND                                                                                               Enhancement (3)
  * His2AvD*^05146^     Suppression (5)                                                                                           Suppression (3)                                                                                          ND                                                                                               Enhancement (3)
  * Kis^BG01657^*       Suppression (5)                                                                                           Suppression (2)                                                                                          NE                                                                                               NE
  * Pc^3^*              Suppression (5)                                                                                           Suppression (5)                                                                                          ND                                                                                               Enhancement (4)
  * Pc^f01890^*         Suppression (5)                                                                                           Suppression (2)                                                                                          ND                                                                                               Enhancement (1)
  * pho^1^*             Suppression (5)                                                                                           Suppression (1)                                                                                          Enhancement (1)                                                                                  NE
  * Scm^D1^*            Suppression (5)                                                                                           Suppression (4)                                                                                          ND                                                                                               ND
  * Su(z)2^1^*          Suppression (5)                                                                                           Suppression (4)                                                                                          ND                                                                                               Enhancement (1)
  * Su(z)2^1.a1^*       Suppression (5)                                                                                           Suppression (5)                                                                                          NE                                                                                               NE
  * Su(z)2^1.b7^*       Suppression (5)                                                                                           Suppression (3)                                                                                          Enhancement (1)                                                                                  NE
  * Su(z)2^k06344^*     Suppression (5)                                                                                           Suppression (3)                                                                                          Enhancement (1)                                                                                  NE
  * Su(z)12^3^*         Suppression (5)                                                                                           Suppression (2)                                                                                          NE                                                                                               NE
  * tara^1^*            Suppression (5)                                                                                           Suppression (1)                                                                                          ND                                                                                               NE
  * tou*^2^             Suppression (5)                                                                                           Suppression (2)                                                                                          Enhancement                                                                                      NE
  * brm^2^*             Suppression (5)                                                                                           Suppression (2)                                                                                          NE                                                                                               NE
  * trx^KG08639^*       Suppression (5)                                                                                           Suppression (1)                                                                                          NE                                                                                               NE
  Enhancers                                                                                                                                                                                                                                                                                                                                 
  * E(Pc)^w3^*          Enhancement (4)                                                                                           Enhancement (3)                                                                                          Suppression (1)                                                                                  ND
  * E(Pc)^D4^*          Enhancement (5)                                                                                           Enhancement (5)                                                                                          Suppression (1)                                                                                  ND
  * Mi-2^j3D4^*         Enhancement (4)                                                                                           Enhancement (1)                                                                                          Suppression (4)                                                                                  NE
  * Mi-2^EY08138^*      Enhancement (5)                                                                                           Enhancement (1)                                                                                          ND                                                                                               ND
  * Su(z)3^1^*          Enhancement (5)                                                                                           Enhancement (4)                                                                                          Suppression (1)                                                                                  ND
  * tara^BG01673^*      Pupal lethal                                                                                              Enhancement (4)                                                                                          Lethal                                                                                           Lethal

The effects of suppression or enhancement were ranked with scores from 1 to 5, with "1" the weakest and "5" the strongest; NE, no effect; ND, not determined.

These crosses were maintained at 25°.

These crosses were maintained at 22-23°; see *Materials and Methods* for the detailed genotypes analyzed.

Next, we tested whether PcG mutants could modify phenotypes caused by overexpression of *dE2f1* alone or together with *dDp*, as we described previously ([@bib51]; [@bib38]). We found that PcG mutants weakly enhanced phenotypes associated with *dE2f1* overexpression ([Table 3](#t3){ref-type="table"}), which is consistent with the PcG role in repressing dE2F1 activities. Furthermore, to examine whether the PcG genes affect RNAi efficiency, we used the *GMR-w^IR^* line and tested several PcG mutants, including *[E(Pc)^w3^](http://flybase.org/reports/FBal0152587.html)*, *[Psc^1^](http://flybase.org/reports/FBal0013980.html)*, *[Psc^e23^](http://flybase.org/reports/FBal0045015.html)*, *[Psc^e25^](http://flybase.org/reports/FBal0045016.html)*, *[Psc^h28^](http://flybase.org/reports/FBal0045019.html)*, *Su(z)2^1.b8^*, *[Su(z)2^k06344^](http://flybase.org/reports/FBal0064441.html)*, *Su(z)2^4d1^*, *Su(z)2^s15^*, *Su(z)2^s20^*, *Su(z)2^s95^*, and *Su(z)2^sM^*. We did not observe any of these lines affected the light yellow eye color caused by knocking down of *[white](http://flybase.org/reports/FBgn0003996.html)* gene (data not shown), suggesting that *[Psc](http://flybase.org/reports/FBgn0005624.html)* and *[Su(z)2](http://flybase.org/reports/FBgn0008654.html)* does not affect RNAi process. Taken together, these genetic analyses revealed *in vivo* regulation of dE2F1 by the PcG complexes, suggesting that several PcG complexes cooperate to restrict dE2F1-dependent cell proliferation.

Su(z)2 represses the expression of *dE2f1* and critical proliferation target genes {#s12}
----------------------------------------------------------------------------------

To examine the role of Su(z)2 in regulating dE2F1 activity, we depleted *[Su(z)2](http://flybase.org/reports/FBgn0008654.html)* in cultured *Drosophila* SL2 cells and analyzed the expression of *dE2f1* and a subset of critical proliferation target genes by qRT-PCR. Depletion of *[Su(z)2](http://flybase.org/reports/FBgn0008654.html)* significantly increased the transcription of *dE2f1* and dE2F1 target genes including *PCNA* and *dCycE* ([Figure 4A](#fig4){ref-type="fig"}). In contrast, reduction of *[Su(z)2](http://flybase.org/reports/FBgn0008654.html)* had little effect on *Rbf1* transcription and weakly up-regulates the expression of *dE2f2* gene ([Figure 4A](#fig4){ref-type="fig"}). These results suggest that Su(z)2 constrains cell proliferation by regulating the expression of *dE2f1*, *PCNA*, and *dCycE*.

![Su(z)2 regulates the transcription of *dE2f1* and some of the dE2F1 target genes. (A) Knocking down *Su(z)2* (gray bars) leads to up-regulation of *dE2f1*, and some of the dE2F1 target genes, such as *PCNA*, *dCycE*, and to a less extent *dE2f2* and no effect of *Rbf1*, based on qRT-PCR assay. The samples treated with *dE2f1-dsRNAs* (white bars) serve as a positive control, and *T7-dsRNA* treated samples are negative controls. (B) Codepletion (gray bars) of *Su(z)2* and *dE2f1* suppresses the effect of *dE2f1-dsRNA* treatment and leads to increased expression of *dE2f1*, *PCNA*, *dCycE*, *stg*, and *mcm5*. The total dsRNAs are normalized with *T7*-dsRNA. (C and D) Effect of dsRNA treatment of the growth of SL2 cells: knocking down of *Su(z)2* (C), but not Psc (D), suppresses the effect of *dE2f1-dsRNA* treatment at day 5. For each sample, the total amount of dsRNA is normalized with *white*-dsRNA and cell viability was determined by using the dimethyltriazoldiphenyl tetrazolium-formazan assay after 1, 3 or 5 days of dsRNA treatment.](1651f4){#fig4}

To test whether depletion of *[Su(z)2](http://flybase.org/reports/FBgn0008654.html)* could rescue the effect of reduced *dE2f1* transcription, we codepleted *[Su(z)2](http://flybase.org/reports/FBgn0008654.html)* and *dE2f1* in *Drosophila* SL2 cells and measured the effect on dE2F target gene expression. As shown in [Figure 4B](#fig4){ref-type="fig"}, we observed that compared to knocking down *dE2f1* alone, codepletion of Su(z)2 and dE2F1 significantly increased the expression of *dE2f1* and several dE2F1 target genes, including *PCNA*, *dCycE*, *[string](http://flybase.org/reports/FBgn0003525.html)* (*[stg](http://flybase.org/reports/FBgn0003525.html)*, encoding *Drosophila* CDC25 phosphatase), and *[Mcm5](http://flybase.org/reports/FBgn0017577.html)*. These results suggest that reduction of *[Su(z)2](http://flybase.org/reports/FBgn0008654.html)* is sufficient to alleviate the effect of *dE2f1* depletion in SL2 cells, which is consistent with our observations that *[Su(z)2](http://flybase.org/reports/FBgn0008654.html)* mutants can suppress the *dE2f1-dsRNA* phenotypes.

Next, to determine the biological consequence of codepleting *dE2f1* and *[Su(z)2](http://flybase.org/reports/FBgn0008654.html)*, we conducted the dimethyltriazoldiphenyl tetrazolium-formazan cell viability assays, also known as the MTT assay, to analyze the kinetics of cell proliferation in SL2 cells. This assay is based on mitochondrial reduction of a tetrazolium salt to a colored formazan salt, which can be quantified by measuring the absorbance at 570 nm, in living cells ([@bib26]). Depletion of *dE2f1* impairs cellular proliferation, and cells arrest after 5 days of dsRNA treatment ([Figure 4C](#fig4){ref-type="fig"}). Reducing *[Su(z)2](http://flybase.org/reports/FBgn0008654.html)* levels alone has little effect on cell proliferation ([Figure 4C](#fig4){ref-type="fig"}); however, codepletion of *dE2f1* and *[Su(z)2](http://flybase.org/reports/FBgn0008654.html)* significantly rescues the proliferation defects associated with *dE2f1* depletion. In contrast, codepletion of *dE2f1* and *[Psc](http://flybase.org/reports/FBgn0005624.html)* (or *[E(Pc)](http://flybase.org/reports/FBgn0000581.html)*; data not shown) had no effect in rescue of this defect ([Figure 4D](#fig4){ref-type="fig"}), which is consistent with our genetic analyses ([Table 3](#t3){ref-type="table"}). Interestingly, depleting Psc alone blocked cell proliferation ([Figure 4D](#fig4){ref-type="fig"}), consistent with the recently reported role of Psc in regulating the G2-M progression by directly affecting Cyclin B degradation ([@bib37]). In contrast to Psc, depleting Su(z)2 does not affect cell proliferation ([Figure 4C](#fig4){ref-type="fig"}), suggesting that unlike Psc, Su(z)2 may not regulate the turnover of CycB and nuclear division. Taken together, these results suggest that Su(z)2 represses the transcription of *dE2f1* and certain dE2F1 target genes that are required for cell proliferation.

Discussion {#s13}
==========

PcG and TrxG complexes play important roles in maintaining the expression of many developmental genes in metazoans, and deregulation of their functions has been linked to human malignancy. Here we identify genetic interactions between multiple components of PcG complexes and a key cell-cycle regulator, E2F1, in *Drosophila*. We find that mutations compromising the PcG functions suppress the defects caused by dE2F1-RNAi in the *Drosophila* eye and wing. Our results suggest that PcG complexes may regulate the key cell-cycle regulator dE2F1 and a subset of dE2F1 target genes in *Drosophila* development. To our knowledge, this is the first work to show functionally that dE2F1 is affected by PcG proteins, especially by Su(z)2.

Mutant alleles of *Su(z)2*, but not *Psc*, suppress *dE2f1-dsRNA* phenotypes {#s14}
----------------------------------------------------------------------------

Our dominant modifier genetic screen using Exelixis *Df* mutants identified *[Su(z)2](http://flybase.org/reports/FBgn0008654.html)* as a strong suppressor of the *dE2F1-RNAi* phenotypes. By expanding our studies to mutations of other components of the PcG complexes, we found a strong genetic link between PcG and E2F1 activity. However, as summarized in [Table 3](#t3){ref-type="table"}, not all of mutant alleles of the PcG genes tested modified the *dE2f1-dsRNA* phenotypes. For example, although Su(z)2 and Psc are paralogs and their functions are partially redundant ([@bib7]; [@bib61]; [@bib49]; [@bib62]; [@bib52]), we found that only Su(z)2 could modify the E2F1-RNAi phenotypes. In addition, biochemical analyses suggest that both Psc and Su(z)2 share similar activities in DNA binding, chromatin compacting, and chromatin remodeling inhibition ([@bib32]). However, in multiple analyses, including genetic tests based on phenotypes caused by overexpression or knockdown of dE2F1, and experiments in cultured SL2 cells, we observed a consistent pattern of interaction with *[Su(z)2](http://flybase.org/reports/FBgn0008654.html)* but not *[Psc](http://flybase.org/reports/FBgn0005624.html)* ([Figure 2](#fig2){ref-type="fig"}, [Figure 4](#fig4){ref-type="fig"}, [Table 3](#t3){ref-type="table"}).

There are several potential explanations to these observations. First, this screen was designed to identify the dominant modifiers and perhaps mutations within some PcG genes remain above a critical threshold during development. Second, the *dE2f1-dsRNA* phenotypes in both the eye and wing are caused by reduction of dE2F1 protein levels and dE2F1 activity ([@bib38]). Because dE2F1 levels vary during the cell cycle ([@bib48]), the dynamic interactions between dE2F1 and PcG gene products may determine whether a phenotypic interaction can be visualized in these adult tissues. Perhaps Su(z)2 has a more important role in the tissues we used to screen for E2F1 modifiers, and our genetic tests alone still cannot rigorously rule out the potential redundant functions of Su(z)2 and Psc. Third, as Psc regulates mitotic progression independently of the transcriptional functions of the canonical PcG complexes, it is likely that Su(z)2 and Psc regulate different sets of targets ([@bib37]). Unlike Psc ([Figure 4D](#fig4){ref-type="fig"}), depleting Su(z)2 alone does not affect cell proliferation ([Figure 4C](#fig4){ref-type="fig"}), suggesting that Su(z)2 may not have a role in regulating CycB degradation. Nevertheless, the mitotic effects of Psc may mask its role in regulating *dE2f1* transcription. Thus, our results are not sufficient to exclude the possibility that Psc might have a redundant role with Su(z)2 in repressing the expression of *dE2f1*. Additional molecular and biochemical analyses are necessary to further dissect the difference between these two paralog proteins.

The *dE2f1* gene is a target repressed by PcG complexes {#s15}
-------------------------------------------------------

There are several lines of evidence suggesting that dE2F1 activity is regulated by PcG and TrxG complexes. Mutant alleles of subunits of the SWI/SNF chromatin-remodeling complex ([@bib24]), such as *[brahma](http://flybase.org/reports/FBgn0000212.html)* (*[brm](http://flybase.org/reports/FBgn0000212.html)*) and *[moira](http://flybase.org/reports/FBgn0002783.html)* (*[mor](http://flybase.org/reports/FBgn0002783.html)*), have been shown to dominantly modify the rough eye phenotype caused by overexpression of *dE2f1* and its heterodimeric partner *dDp* ([@bib51]). Subunits of the Domino chromatin-remodeling complex (PcG-like L3mbt and the related dSfmbt) negatively regulate transcription of an artificial *dE2f1* reporter gene ([@bib33]). ChIP assays have identified both Ph and Pho on the promoter and coding regions of the *dE2f1* gene in *Drosophila* embryos ([@bib42]).

PcG complexes regulate methylation of H3K27 in *Drosophila* ([@bib10]), we therefore analyzed the status of H3K27 methylation during development or in several *Drosophila* cell lines using chromatin immunoprecipitation (ChIP) followed by microarray hybridization (ChIP-chip) or high-throughput sequencing (ChIP-Seq) data sets deposited to modENCODE ([@bib13]) (<http://modencode.oicr.on.ca/fgb2/gbrowse/fly/>). We found that the genomic loci of *dE2f1*, *dCycE* and *[stg](http://flybase.org/reports/FBgn0003525.html)* display mono-, di-, or trimethylation of H3K27 (H3K27me1/2/3) during development or in *Drosophila* cell lines, including SL2, Kc, and BG3 cells (see [Figure S1](http://www.g3journal.org/lookup/suppl/doi:10.1534/g3.112.004333/-/DC1/FigureS1.pdf), [Figure S2](http://www.g3journal.org/lookup/suppl/doi:10.1534/g3.112.004333/-/DC1/FigureS2.pdf), [Figure S3](http://www.g3journal.org/lookup/suppl/doi:10.1534/g3.112.004333/-/DC1/FigureS3.pdf), and [Figure S4](http://www.g3journal.org/lookup/suppl/doi:10.1534/g3.112.004333/-/DC1/FigureS4.pdf) for details), suggesting that PcG may directly regulate the expression of these genes. *dCycE* and *[stg](http://flybase.org/reports/FBgn0003525.html)* are critical dE2F1 target genes, which regulate the G1/S-phase and the G2/M-phase transition of the cell cycle, respectively ([@bib19]; [@bib18]). We did not observe obvious H3K27me modification of other dE2F1 target genes such as *PCNA* and *[Mcm5](http://flybase.org/reports/FBgn0017577.html)* (data not shown), suggesting that the effect of Su(z)2 on expression of these genes ([Figure 4B](#fig4){ref-type="fig"}) is likely indirect through *dE2f1*. Together, these observations suggest that PcG complexes may repress the expression of *dE2f1* and a subset of dE2F1 target genes during development.

These observations are consistent with our genetic studies and suggest the suppressive effect of PcG mutants on *dE2f1-dsRNA* phenotypes is caused by derepression of *dE2f1* and certain dE2F1 target genes, which compensates for the effect of *dE2f1*-depletion. Together with previous published observations linking PcG complexes to cell-cycle regulators, such as *dCycA* ([@bib35]), *dCycB* ([@bib42]), *dCycE* ([@bib6]), and *dE2f1* ([@bib42]), our observations provide further support for the role of PcG in repressing the transcription of cell-cycle genes, including *dE2f1*, *dCycE*, and *[stg](http://flybase.org/reports/FBgn0003525.html)* ([Figure 4](#fig4){ref-type="fig"} and [Figure S4](http://www.g3journal.org/lookup/suppl/doi:10.1534/g3.112.004333/-/DC1/FigureS4.pdf)).

Regulation of the key cell-cycle regulators by PcG complexes may present a general mechanism to coordinate cellular differentiation and proliferation during development. Disrupting the coordination between differentiation and proliferation may result in abnormal development and may contribute to tumorigenesis. Consistent with this notion, accumulating evidence shows that the PcG complexes are misregulated in a wide variety of human cancers ([@bib50]; [@bib2]; [@bib3]). This study, together with previous reports in *Drosophila* ([@bib51]; [@bib6]; [@bib24]; [@bib35]; [@bib33]; [@bib42]), suggest that mutations compromising PcG activity would elevate E2F activity, thereby providing cells with a strong tumorigenic advantage. Further studies are necessary to elucidate how these two important regulatory mechanisms are coordinated during cellular differentiation and proliferation in development.
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